DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Stemline Therapeutics Q4 EPS $(0.38) Up From $(0.92) YoY, Sales $11.8M

Stemline Therapeutics (NASDAQ:STML) reported quarterly losses of $(0.38) per share. This is a 58.7 percent increase over losses of $(0.92) per share from the same period last year. The company reported $11.8 million in

Benzinga · 03/13/2020 20:48

Stemline Therapeutics (NASDAQ:STML) reported quarterly losses of $(0.38) per share. This is a 58.7 percent increase over losses of $(0.92) per share from the same period last year. The company reported $11.8 million in sales this quarter.